Reported 4 months ago
Sarepta Therapeutics, Inc. (SRPT) is featured prominently in billionaire Glenn Russell Dubin’s list of stock picks, showing a remarkable upside potential of 226.16%. This biotech company specializes in developing genetic therapies for rare neuromuscular disorders, and recently reported a 70% increase in total net product revenue. Despite operational challenges, including delays and a patient safety incident, Sarepta's strong pipeline and Dubin's confidence in its capabilities position it as a strong long-term investment option.
Source: YAHOO